Is Adagrasib included in the reimbursable drug list of medical insurance?

Adagrasib is a targeted drug specifically used to treat patients with non-small cell lung cancer with KRAS G12C mutations. It has not yet been approved for marketing in China. Therefore, this drug has not yet been included in my country's medical insurance reimbursement list. Patients in domestic hospitals cannot obtain support for this drug through medical insurance channels, and their purchase and use need to be resolved through overseas channels.

Since it is not marketed in China, access channels for adagrasib are relatively limited. Domestic patients mainly rely on overseas medical institutions or third-party drug purchasers to obtain the drug. Due to R&D costs and market pricing factors, the price of original drugs in the United States is generally high. The price of a box of drugs may be as high as hundreds of thousands of yuan. For most patients, the financial burden is heavy and it is difficult to maintain long-term treatment.

In comparison, some countries such as Laos have launched generic drugs of adagrasibu. The ingredients of the drug are basically the same as the original drug and have a certain degree of efficacy. The Lao version of generic drugs sells for about more than 3,000 yuan per box, which is significantly lower than the original drug, providing a more feasible alternative for patients under financial pressure. However, when choosing generic drugs, patients still need to use them rationally under the guidance of a doctor to avoid the risks caused by self-medication.
Generally speaking, adagrasib is not yet included in my country's medical insurance coverage. The original drug is expensive and difficult to obtain. Laotian generic drugs have become a choice for many patients to weigh efficacy and economy. In the future, if the drug is successfully launched in China and included in medical insurance, it is expected to reduce the financial burden on patients and improve treatment accessibility.
Reference: https://www.krazati.com/